199 related articles for article (PubMed ID: 18945496)
21. Increased levels of interleukin-1beta and soluble intercellular adhesion molecule-1 in cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Mehta SP; Coyle PK; Wisniewski HM
J Infect Dis; 1997 Mar; 175(3):689-92. PubMed ID: 9041345
[TBL] [Abstract][Full Text] [Related]
22. Serum and cerebrospinal fluid levels of cytokines in acute encephalopathy associated with human herpesvirus-6 infection.
Ichiyama T; Ito Y; Kubota M; Yamazaki T; Nakamura K; Furukawa S
Brain Dev; 2009 Nov; 31(10):731-8. PubMed ID: 19114298
[TBL] [Abstract][Full Text] [Related]
23. Cerebrospinal fluid levels of cytokines in non-herpetic acute limbic encephalitis: comparison with herpes simplex encephalitis.
Ichiyama T; Shoji H; Takahashi Y; Matsushige T; Kajimoto M; Inuzuka T; Furukawa S
Cytokine; 2008 Oct; 44(1):149-53. PubMed ID: 18722137
[TBL] [Abstract][Full Text] [Related]
24. Sequential 3-D MRI frontal volume changes in subacute sclerosing panencephalitis.
Kanemura H; Aihara M; Okubo T; Nakazawa S
Brain Dev; 2005 Mar; 27(2):148-51. PubMed ID: 15668056
[TBL] [Abstract][Full Text] [Related]
25. Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington's disease.
Constantinescu R; Romer M; Oakes D; Rosengren L; Kieburtz K
Parkinsonism Relat Disord; 2009 Mar; 15(3):245-8. PubMed ID: 19056308
[TBL] [Abstract][Full Text] [Related]
26. [Evaluation of cerebrospinal fluid proteins in patients with subacute sclerosing panencephalitis (SSPE)].
Rosnowska M; Sobczyk W; Cendrowski W; Karkowska B
Neurol Neurochir Pol; 1992; 26(1):27-33. PubMed ID: 1528364
[TBL] [Abstract][Full Text] [Related]
27. Increased levels of beta 2-microglobulin, soluble interleukin-2 receptor, and soluble CD8 in patients with subacute sclerosing panencephalitis.
Mehta PD; Kulczycki J; Mehta SP; Sobczyk W; Coyle PK; Sersen EA; Wisniewski HM
Clin Immunol Immunopathol; 1992 Oct; 65(1):53-9. PubMed ID: 1382909
[TBL] [Abstract][Full Text] [Related]
28. Increased insulin-like growth factor-1 levels in cerebrospinal fluid of advanced subacute sclerosing panencephalitis patients.
Yılmaz D; Yüksel D; Gökkurt D; Oguz H; Anlar B
Eur J Paediatr Neurol; 2016 Jul; 20(4):611-5. PubMed ID: 27061773
[TBL] [Abstract][Full Text] [Related]
29. Two-dimensional polyacrylamide gel electrophoresis of serum and cerebrospinal fluid proteins in multiple sclerosis and subacute sclerosing panencephalitis.
Dams E
Acta Neurol Belg; 1986; 86(4):233-42. PubMed ID: 3766112
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal one-year study of levels and stoichiometry of neurofilament heavy and light chain concentrations in CSF in patients with multiple system atrophy.
Petzold A; Thompson EJ; Keir G; Quinn N; Holmberg B; Dizdar N; Wenning GK; Rascol O; Tolosa E; Rosengren L
J Neurol Sci; 2009 Apr; 279(1-2):76-9. PubMed ID: 19195665
[TBL] [Abstract][Full Text] [Related]
31. A new brain specific protein in the cerebrospinal fluid (CSF) of subacute sclerosing panencephalitis (SSPE).
Doutriaux C; Alle-Ando L; Attias J; Clerc M
Biomedicine; 1980 Feb; 33(1):24-6. PubMed ID: 7370384
[TBL] [Abstract][Full Text] [Related]
32. Neurofilament heavy chain and heat shock protein 70 as markers of seizure-related brain injury.
Rejdak K; Kuhle J; Rüegg S; Lindberg RL; Petzold A; Sulejczak D; Papuc E; Rejdak R; Stelmasiak Z; Grieb P
Epilepsia; 2012 May; 53(5):922-7. PubMed ID: 22509781
[TBL] [Abstract][Full Text] [Related]
33. Drug-indiced aseptic meningitis: development of subacute sclerosing panencephalitis following repeated intraventricular infusion therapy with interferon alpha/beta.
Imataka G; Nakagawa E; Yamanouchi H; Arisaka O
Cell Biochem Biophys; 2011 Dec; 61(3):699-701. PubMed ID: 21748242
[TBL] [Abstract][Full Text] [Related]
34. Elevated quinolinic acid levels in cerebrospinal fluid in subacute sclerosing panencephalitis.
Inoue H; Matsushige T; Ichiyama T; Okuno A; Takikawa O; Tomonaga S; Anlar B; Yüksel D; Otsuka Y; Kohno F; Hoshide M; Ohga S; Hasegawa S
J Neuroimmunol; 2020 Feb; 339():577088. PubMed ID: 31733567
[TBL] [Abstract][Full Text] [Related]
35. Soluble tumor necrosis factor receptor 1 and tissue inhibitor of metalloproteinase-1 in hemolytic uremic syndrome with encephalopathy.
Shiraishi M; Ichiyama T; Matsushige T; Iwaki T; Iyoda K; Fukuda K; Makata H; Matsubara T; Furukawa S
J Neuroimmunol; 2008 May; 196(1-2):147-52. PubMed ID: 18410971
[TBL] [Abstract][Full Text] [Related]
36. Soluble tumour necrosis factor receptors sTNFR1 and sTNFR2 are produced at sites of inflammation and are markers of arthritis activity in Behçet's disease.
Turan B; Pfister K; Diener PA; Hell M; Möller B; Boyvat A; Ergin S; Villiger PM
Scand J Rheumatol; 2008; 37(2):135-41. PubMed ID: 18415772
[TBL] [Abstract][Full Text] [Related]
37. Subacute sclerosing panencephalitis (SSPE) associated with congenital measles infection.
Simşek E; Oztürk A; Yavuz C; Kocabay K
Turk J Pediatr; 2005; 47(1):58-62. PubMed ID: 15884631
[TBL] [Abstract][Full Text] [Related]
38. Subacute sclerosing panencephalitis: is there something different in the younger children?
Yilmaz D; Aydin OF; Senbil N; Yuksel D
Brain Dev; 2006 Nov; 28(10):649-52. PubMed ID: 16829007
[TBL] [Abstract][Full Text] [Related]
39. Pseudotumor cerebri secondary to subacute sclerosing panencephalitis.
Ayçiçek A; Işcan A; Ceçe H
Pediatr Neurol; 2009 May; 40(5):371-6. PubMed ID: 19380074
[TBL] [Abstract][Full Text] [Related]
40. [Therapy of subacute sclerosing panencephalitis with intrathecal alpha-interferon].
Grimaldi LM; Maimone D
Acta Neurol (Napoli); 1989; 11(2-3):211-5. PubMed ID: 2782117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
